Suppr超能文献

[孕妇肢端肥大症的管理]

[Management of acromegaly in pregnant woman].

作者信息

Ben Salem Hachmi L, Kammoun I, Bouzid C, Smida H, Nagi S, Turki Z, Ben Slama C

机构信息

Service d'endocrinologie et des maladies métaboliques. institut national de nutrition, 11 rue Djebel Lakhdhar, Bas Saadoun, Tunis, Tunisia.

出版信息

Ann Endocrinol (Paris). 2010 Feb;71(1):60-3. doi: 10.1016/j.ando.2009.10.002. Epub 2009 Nov 18.

Abstract

Pregnancy in acromegalic patients is an infrequent event, due to perturbed gonadotroph function. On the other hand, pregnancy may cause an enlargement of the adenoma or an increase of growth hormone (GH) secretion. We report the case of a 26-year-old woman with a GH-secreting pituitary macroadenoma who was operated by transphenoidal approach. After surgery, she had a persistent acromegaly due to an intrasellar tumour. She was treated by lanreotide. After one year, the patient had married and became pregnant. Lanreotide was stopped when the diagnosis of pregnancy was established. The follow-up of this patient showed a progressive increase of IGF1 level during pregnancy without tumoral syndrome or visual troubles. No metabolic complication was detected. The patient went to term and gave birth to a healthy baby. In postpartum, the IGF1 level was normal, but the brain MRI revealed a 10mm intrasellar tumour. The pituitary adenoma was not significantly enlarged during pregnancy. Therefore, pregnancy doesn't influence acromegaly in young women well controlled by medical treatment.

摘要

由于促性腺激素功能紊乱,肢端肥大症患者怀孕的情况并不常见。另一方面,怀孕可能会导致腺瘤增大或生长激素(GH)分泌增加。我们报告一例26岁分泌GH的垂体大腺瘤女性患者,该患者接受了经蝶窦手术。术后,由于鞍内肿瘤,她仍患有持续性肢端肥大症。她接受了兰瑞肽治疗。一年后,该患者结婚并怀孕。确诊怀孕后停用兰瑞肽。对该患者的随访显示,孕期IGF1水平逐渐升高,无肿瘤综合征或视觉问题。未检测到代谢并发症。患者足月分娩,产下一名健康婴儿。产后,IGF1水平正常,但脑部MRI显示鞍内有一个10mm的肿瘤。孕期垂体腺瘤未明显增大。因此,怀孕对接受药物良好控制的年轻女性肢端肥大症没有影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验